1031401-20-3

Upstream product

• 1031401-18-9 3-(4-((tert-butyldiphenylsilyl)oxy)but-2-yn-1-yl)-5-(4-(1-methylethoxy)phenyl)-5-methylimidazolidine-2,4-dione 

Downstream Products

• 1031401-23-6 3-(4-bromobut-2-yn-1-yl)-5-(4-(1-methylethoxy)phenyl)-5-methylimidazolidine-2,4-dione 
• 1031400-31-3 3-(4-(4-(1,1,1,3,3,3-hexafluoro-2-hydroxypropan-2-yl)-2,6-di-n-propylphenoxy)but-2-yn-1-yl)-5-(4-(1-methylethoxy)phenyl)-5-methylimidazolidine-2,4-dione 

Relevant academic research and scientific papers

Discovery of a 2-hydroxyacetophenone derivative as an outstanding linker to enhance potency and β-selectivity of liver X receptor agonist

Our research found that the 2-hydroxyacetophenone derivative is an outstanding linker between the 1,1-bistrifluoromethylcarbinol moiety and the imidazolidine-2,4-dione moiety to enhance the potency and β-selectivity of liver X receptor (LXR) agonist in ou

SUBSTITUTED CARBINOL COMPOUND

There is provided a novel LXRβ agonist useful as a preventative and/or therapeutic agent for arteriosclerosis; arteriosclerosis such as those resulting from diabetes; hyperlipidemia; hypercholesterolemia; lipid-related diseases; inflammatory diseases caus